Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants

Journal of Clinical Gastroenterology

Volumn 40, Issue 7, 2006, Pages 596-601

  Wilcox, Gilbert M ^a,b   Mattia, Anthony R ^a  

^a MAINE MEDICAL CENTER   (United States)

^b Maine Gastroenterology Associates   (United States)

Author keywords

Budd Chiari; Celiac disease; Colonic neoplasia; Hyperhomocysteinemia; Hypomethylation; Methylenetetrahydrofolate reductase; MTHFR; Neural tube defects; Osteoporosis; Sprue

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GLUTEN FREE DIET; HEREDITY; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

AGED; CELIAC DISEASE; COMORBIDITY; DUODENUM; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION;

EID: 33747476815     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200608000-00007     Document Type: Article

References (52)

1. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med. 1989;114:473-501.
2. McCully KS. Homocysteine and vascular disease. Nat Med. 1996;2:386-389.
3. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.
4. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158:2101-2106.
5. den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998;80:874-877.
6. Margaglione M, D'Andrea G, d'Addedda M, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the co-existence of the FV Leiden and the prothombin A2O210 mutation. Thomb Haemost. 1998;79:907-911.
7. Grigg AP. Deep venous thrombosis as the presenting feature in a patient with celiac disease and homocysteinaema. Aust NZ J Med. 1999;29:566-567.
8. Kremer Hovinga JA, Baerlocher G, Wuillemin WA, et al. Deep venous thrombosis of the leg in acquired thrombophilia-hyperhomocysteinemia as a consequence of undetected celiac disease. Ther Umsch. 1999;56:519-522.
9. Andres E, Pflumio F, Knab MC, et al. Splenic vein thrombosis and celiac disease: a fortuitous association? Presse Med. 2000;29:1933-1934.
10. Lim PO, Tzemos N, Farquharson CAJ, et al. Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinemia and vascular endothelial dysfunction. J Hum Hypertens. 2002;16:411-415.
11. Hozyasz K, Milanowski A. Hyperhomocysteinemia in a celiac disease heterozyote for the two common mutations (C677T and A1298C) of the methylenetetrahydrofolate reductase gene. Case report. Med Wieku Rozwoj. 2002;6:57-61.
12. Gefel D, Doncheva M, Ben-Valid E, et al. Recurrent stroke in a young patient with celiac disease and hyperhomocysteinemia. IMAJ. 2002;4:222-223.
13. Gabrielli M, Santoliquido A, Gasbarrini G, et al. Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link? Thromb Haemost. 2003;89:203-204.
14. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-1194.
15. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiological approach to the spectrum of gluten sensitivity. Gastroenterology. 1992;102:330-354.
16. Harmon DL, Woodside JV, Yarnell JWG, et al. The common "thermolabile" variant of methelenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. Q J Med. 1996;89:571-577.
17. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
18. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Gen. 1995;10:111-113.
19. de Franchis R, Mancini FP, D'Angelo A, et al. Elevated total plasma homocysteine and C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet. 1996;59:262-264.
20. Gallagher PM, Meleady R, Shields DC, et al. Homocysteine and risk of premature coronary heart disease: evidence for a common gene mutation. Circulation. 1996;94:2154-2158.
21. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reducatase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56:4862-4864.
22. McAndrew PE, Brandt JT, Pearl DK, et al. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. Thromb Res. 1996;83:195-198.
23. Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032-2036.
24. Cattaneo M, Tsai MY, Bucciarelli P, et al. A common mutation in the methylenetetrahydrofolate reducatase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (Factor V: Q506). Arterioscler Thromb Vasc Biol. 1997;17:1662-1666.
25. Park KS, Podskarbi T, Yoo EA, et al. The C677T mutuation in the methylenetetrahydrofolate reductase gene in Koreans. Korean J Genet. 1998;20:23-28.
26. Franco RF, Araujo AG, Guerreiro JF, et al. Analysis of the C677T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost. 1998;79:119-121.
27. Shaw GM, Rozen R, Finnell RH, et al. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol. 1998;148:30-37.
28. Vanegas OC, Giusti B, Fernandez CMR, et al. Frequency of Factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb Haemost. 1998;79:883-884.
29. Hanson NQ, Aras O, Yang F, et al. C677T and A1298C Polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001;47:661-666.
30. Qi Z, Hoffman G, Kurtycz D, et al. Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin. Genet Med. 2003;5:458-459.
31. Rozen R. Genetic modulation of homocysteinemia. Semin Thromb Hemostas. 2000;26:255-261.
32. Upadhyay R, Park RH, Russell RI, et al. Acute mesenteric ischemia: a presenting feature of celiac disease? Br Med J (Clin Res Ed). 1987;295:958-959.
33. Boudhina T, Ghram N, Ben Becher S, et al. Budd-Chiari syndrome and total villous atrophy in children: apropos of 3 case reports. Tunis Med. 1990;68:59-62.
34. Hamdi A, Ayachi R, Saad H, et al. Hemiplegia revealing Budd-Chiari syndrome associated with celiac disease in an infant. Presse Med. 1900;19:1011-1012.
35. Marteau P, Cadranel JF, Messing B, et al. Association of hepatic vein obstruction and celiac disease in North African subjects. J Hepatol. 1994;20:650-653.
36. Aguirrebarrena G, Pulcinelli S, Giovannoni AG, et al. Celiac disease and Budd-Chiari syndrome: infrequent association. Rev Esp Enferm Dig. 2001;93:611-612.
37. Manzano ML, Garfia C, Manzanares J, et al. Celiac disease and Budd-Chiarai syndrome: an uncommon association. Gastroenterol Hepatol. 2002;25:159-161.
38. El Younsi S, Nassif T, Kuoch V, et al. Assocation of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol. 2003;27:236-237.
39. Zenjari T, Boruchowicz A, Desreumaux P, et al. Association of coeliac disease and portal venous thrombosis. Gastroenterol Clin Bio. 1995;19:953-954.
40. Hida M, Erreimi N, Ettair S, et al. Associated celiac disease and venous thrombosis. Arch Pediatr. 2000;7:215-216.
41. NarayananMenon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N. Engl J Med. 2004;350:578-585.
42. Giovannucci E, Chen J, Smith-Warner SA, et al. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2003;12:970-979.
43. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
44. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q J Med. 1995;88:763-766.
45. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070-1071.
46. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, et al. Decreased methylene tetrahydrofolate reductase activity due to the C677T mutation in families with spina bifida offspring. J Mol Med. 1996;74:691-694.
47. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350:2033-2041.
48. Mclean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factory for hip fracture in older persons. N Engl J Med. 2004;350:2042-2049.
49. Duggan JM, Duggan AE. Systematic review: the liver in celiac disease. Aliment Pharmacol Ther. 2005;21:515-518.
50. Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatal. 2004; 2:107-112.
51. Adinolfi LE, Ingrosso D, Cesaro G, et al. Hyperhomocysteinemia and MTHFR C677T polymorphism promote steatosis and fibrosis in chronic Hepatitis C. Hepatology. 2005;41:995-1003.
52. Saibeni S, Lecchi A, Meucci G, et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gast Hepatol. 2005;3:574-580.